plateaued on semaglutide for Weight Loss Plateau: Causes & Solutions Weight Loss Plateau on Semaglutide:

Are telehealth weight loss appointments available

But weight loss is not without its risks

(Pabel et al, 2021

Providers should use the opportunity of GLP-1 receptor agonist switching to re-educate patients about the mechanisms of action and set patient expectations, especially with respect to the effects of delayed gastric emptying

July 2024: A study linking patients with type 2 diabetes who were taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs) to an increased risk of a rare and serious eye condition known as nonarteritic anterior ischemic optic neuropathy (NAION)

Nonetheless, the broader safety profile of GLP-1 drugs remains under close watch, particularly as more individuals begin using them for extended periods